Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Gene therapy for rare genetic blindness wins prestigious Champalimaud Vision award

A team of seven researchers collaborating from United States and Britain have found a way to use gene therapy to cure a rare form of childhood blindness that occurs due to a genetic predisposition.

5 Sep 2018

Five microRNAs predict course, recurrence of HPV-negative head and neck cancer

A new method predicts the course of HPV-negative head and neck cancer after radiation chemotherapy.

4 Sep 2018

Breakthrough study sheds light on mechanism underlying Warsaw Breakage Syndrome

Researchers from Tokyo Metropolitan University and the FIRC Institute of Molecular Oncology in Italy have uncovered a previously unknown function of the DDX11 helicase enzyme.

3 Sep 2018

Genetic mutations may drive tumor formation by blurring growth signals

Genetic mutations in a form of non-small cell lung cancer (NSCLC) may drive tumor formation by blurring cells' perception of key growth signals, according to a new laboratory study published August 31, 2018 in Science.

3 Sep 2018

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration issued a Complete Response Letter for the New Drug Application for dasotraline, a novel dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention-deficit hyperactivity disorder.

3 Sep 2018

Research group aims to offer more personalized treatments for pediatric cancers

A new Emmy Noether Independent Junior Research Group at Charité - Universitätsmedizin Berlin is studying the development of pediatric cancers. The research group is being funded by the German Research Foundation (DFG) and will receive €1.7 million over five years.

31 Aug 2018

Finding which chemotherapy regimen is associated with best outcomes for patients with bladder cancer

Patients with muscle-invasive bladder cancer have been shown to benefit from chemotherapy prior to surgical removal of the bladder.

31 Aug 2018

Groundbreaking CURATE.AI platform halts progression of advanced cancer

A translational research team led by the National University of Singapore has harnessed CURATE.AI, a powerful artificial intelligence platform, to successfully treat a patient with advanced cancer, completely halting disease progression.

31 Aug 2018

NUS researchers harness AI platform to treat patient with advanced cancer

31 Aug 2018

Almost half of total funding for publication of clinical trials is not disclosed, finds research

A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed, new research shows. The publications focused on clinical trials that tested new cancer drugs.

31 Aug 2018

Leukogene receives STTR grant to optimize compound for treatment-resistant multiple myeloma

A $2 million phase 2 Small Business Technology Transfer grant to optimize a promising new compound that has shown efficacy in preclinical studies against treatment-resistant multiple myeloma has been awarded to a Medical University of South Carolina startup company, Leukogene Therapeutics, Inc., in collaboration with MUSC researcher and company founder, Nathan G. Dolloff, Ph.D. Dolloff is an assistant professor in the Department of Cell and Molecular Pharmacology & Experimental Therapeutics at MUSC and a member of MUSC Hollings Cancer Center.

31 Aug 2018

New genetic marker could improve diagnosis of prostate cancer

Scientists have discovered a link between certain genetic mutations, the aggressiveness of prostate cancer, risk of developing the disease and poorer survival rates of patients.

30 Aug 2018

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

Shionogi & Co., Ltd. announced today that Mulpleta (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure, is now available throughout the United States.

30 Aug 2018

Rush University’s Ear, Nose and Throat program ranked top in three-state area

Rush University Medical Center's Ear, Nose and Throat program was ranked higher than any other similar program in Illinois, Indiana and Wisconsin, and 24th in the nation, in U.S. News & World Report's annual "Best Hospitals" issue, published in July.

30 Aug 2018

Scientists explore DNA replication errors that can lead to cancer

Scientists at Hollings Cancer Center at the Medical University of South Carolina have found that some cells can divide without a molecule that was previously thought necessary.

30 Aug 2018

Novel approach reveals metabolic vulnerabilities in kidney cancer

In order to halt the growth of cancer cells, you have to know what feeds them. Researchers at the nationally recognized Kidney Cancer Program at UT Southwestern's Harold C. Simmons Comprehensive Cancer Center have developed a novel approach using glucose that may open up new opportunities for therapeutic intervention.

30 Aug 2018

Two Texas-based nonprofits named as recipients of ASTRO 2018 Survivor Circle grants

Two Texas-based nonprofits, Candlelighters of El Paso and the Light and Salt Association, have been named the recipients of the American Society for Radiation Oncology2018 Survivor Circle grants. Each organization will receive a $10,000 grant to aid their cancer support programs and will be recognized at an award ceremony on October 23 during ASTRO's 60th Annual Meeting in San Antonio.

30 Aug 2018

Fertility preservation bill allows cancer patients to have their own biological children

Illinois cancer patients no longer have to choose between costly life-saving treatments and preserving their ability to one day have their own biological children, thanks to a fertility preservation bill signed Aug. 27 by Gov. Bruce Rauner at Northwestern Medicine Prentice Women's Hospital.

29 Aug 2018

Researchers discover reason why many bladder cancer patients do not respond to immunotherapy

Mount Sinai researchers have discovered that a particular type of cell present in bladder cancer may be the reason why so many patients do not respond to the groundbreaking class of drugs known as PD-1 and PD-L1 immune checkpoint inhibitors, which enable the immune system to attack tumors.

29 Aug 2018

Developing a Flexible X-ray Detector

In this interview, Dr. Imalka Jayawardena from the University of Surrey talks about the development of a flexible X-ray detector that will help clinicians analyze X-ray images and deliver targeted doses of radiation when using X-rays as a treatment.

29 Aug 2018

Oncology News and Research

Further Reading

Gene therapy for rare genetic blindness wins prestigious Champalimaud Vision award

Five microRNAs predict course, recurrence of HPV-negative head and neck cancer

Breakthrough study sheds light on mechanism underlying Warsaw Breakage Syndrome

Genetic mutations may drive tumor formation by blurring growth signals

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

Research group aims to offer more personalized treatments for pediatric cancers

Finding which chemotherapy regimen is associated with best outcomes for patients with bladder cancer

Groundbreaking CURATE.AI platform halts progression of advanced cancer

NUS researchers harness AI platform to treat patient with advanced cancer

Almost half of total funding for publication of clinical trials is not disclosed, finds research

Leukogene receives STTR grant to optimize compound for treatment-resistant multiple myeloma

New genetic marker could improve diagnosis of prostate cancer

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

Rush University’s Ear, Nose and Throat program ranked top in three-state area

Scientists explore DNA replication errors that can lead to cancer

Novel approach reveals metabolic vulnerabilities in kidney cancer

Two Texas-based nonprofits named as recipients of ASTRO 2018 Survivor Circle grants

Fertility preservation bill allows cancer patients to have their own biological children

Researchers discover reason why many bladder cancer patients do not respond to immunotherapy

Developing a Flexible X-ray Detector

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News